Pathological Conditions, Signs and Symptoms: News and Research on Guillain-Barre Syndrome

MeSH tree: C23.550.291.500.829.313

FDA approves first RSV vaccine

The first vaccine for respiratory syncytial virus (RSV) has been approved by the U.S. Food and Drug Administration for use in seniors aged 60 and older.

page 2 from 2